Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Generation of a parvovirus B19 vaccine candidate.

Chandramouli S, Medina-Selby A, Coit D, Schaefer M, Spencer T, Brito LA, Zhang P, Otten G, Mandl CW, Mason PW, Dormitzer PR, Settembre EC.

Vaccine. 2013 Aug 20;31(37):3872-8. doi: 10.1016/j.vaccine.2013.06.062. Epub 2013 Jul 2.

PMID:
23827313
2.

Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.

Lin Y, Kwon T, Polo J, Zhu YF, Coates S, Crawford K, Dong C, Wininger M, Hall J, Selby M, Coit D, Medina-Selby A, McCoin C, Ng P, Drane D, Chien D, Han J, Vajdy M, Houghton M.

J Virol. 2008 Aug;82(15):7492-503. doi: 10.1128/JVI.02743-07. Epub 2008 May 28.

3.

Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.

Lau AL, Yam AY, Michelitsch MM, Wang X, Gao C, Goodson RJ, Shimizu R, Timoteo G, Hall J, Medina-Selby A, Coit D, McCoin C, Phelps B, Wu P, Hu C, Chien D, Peretz D.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11551-6. Epub 2007 Jun 29.

4.

Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.

Vajdy M, Selby M, Medina-Selby A, Coit D, Hall J, Tandeske L, Chien D, Hu C, Rosa D, Singh M, Kazzaz J, Nguyen S, Coates S, Ng P, Abrignani S, Lin YL, Houghton M, O'Hagan DT.

J Gen Virol. 2006 Aug;87(Pt 8):2253-62.

PMID:
16847121
5.

Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.

Lin S, Arcangel P, Medina-Selby A, Coit D, Ng P, Nguyen S, McCoin C, Gyenes A, Hu C, Tandeske L, Phelps B, Chien D.

J Clin Microbiol. 2005 Aug;43(8):3917-24.

6.

Assessment of the target-capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays.

Shyamala V, Arcangel P, Cottrell J, Coit D, Medina-Selby A, McCoin C, Madriaga D, Chien D, Phelps B.

J Clin Microbiol. 2004 Nov;42(11):5199-204.

7.

Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles.

Otten G, Schaefer M, Greer C, Calderon-Cacia M, Coit D, Kazzaz J, Medina-Selby A, Selby M, Singh M, Ugozzoli M, zur Megede J, Barnett SW, O'Hagan D, Donnelly J, Ulmer J.

J Virol. 2003 May;77(10):6087-92.

8.

Cloning and comparison of ten gene sequences of a Chilean H. pylori strain with other H. pylori strains revealed higher variability for VacA and CagA virulence factors.

Müller I, Medina-Selby A, Palacios JL, Martinez P, Opazo P, Bruce E, Mancilla M, Valenzuela P, Yudelevich A, Venegas A.

Biol Res. 2002;35(1):67-84.

PMID:
12125208
9.

Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity.

Weiner AJ, Paliard X, Selby MJ, Medina-Selby A, Coit D, Nguyen S, Kansopon J, Arian CL, Ng P, Tucker J, Lee CT, Polakos NK, Han J, Wong S, Lu HH, Rosenberg S, Brasky KM, Chien D, Kuo G, Houghton M.

J Virol. 2001 Aug;75(15):7142-8.

10.

Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.

Baumeister MA, Medina-Selby A, Coit D, Nguyen S, George-Nascimento C, Gyenes A, Valenzuela P, Kuo G, Chien DY.

J Med Virol. 2000 Mar;60(3):256-63.

PMID:
10630956
11.

Use of a novel hepatitis C virus (HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection.

Chien DY, Arcangel P, Medina-Selby A, Coit D, Baumeister M, Nguyen S, George-Nascimento C, Gyenes A, Kuo G, Valenzuela P.

J Clin Microbiol. 1999 May;37(5):1393-7.

12.

Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB.T2.

Baxter GT, Radeke MJ, Kuo RC, Makrides V, Hinkle B, Hoang R, Medina-Selby A, Coit D, Valenzuela P, Feinstein SC.

J Neurosci. 1997 Apr 15;17(8):2683-90.

13.

Replacement of a labile aspartyl residue increases the stability of human epidermal growth factor.

George-Nascimento C, Lowenson J, Borissenko M, Calderón M, Medina-Selby A, Kuo J, Clarke S, Randolph A.

Biochemistry. 1990 Oct 16;29(41):9584-91.

PMID:
2271602
14.

Recombinant subunit vaccines from yeast.

Barr PJ, Gibson HL, Bathurst IC, Sabin EA, Medina-Selby A, Coit D, Valenzuela P.

Biotechnology. 1989;13:319-39. Review. No abstract available.

PMID:
2679931
15.

Expression and processing of biologically active fibroblast growth factors in the yeast Saccharomyces cerevisiae.

Barr PJ, Cousens LS, Lee-Ng CT, Medina-Selby A, Masiarz FR, Hallewell RA, Chamberlain SH, Bradley JD, Lee D, Steimer KS, et al.

J Biol Chem. 1988 Nov 5;263(31):16471-8.

Supplemental Content

Loading ...
Support Center